Xconomy Boston

Gelesis, Inc. Receives $16,000,000 Series A Funding Round

  • Feed Type
  • Date
    1/3/2008
  • Company Name
    Gelesis, Inc.
  • Mailing Address
    222 Berkeley St Boston, MA 02116
  • Company Description
    Gelesis is a Research and Development company for the treatment of obesity.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    OrbiMed
  • Venture Investor
    OrbiMed
  • Venture Investor
    PureTech Ventures
  • Venture Investor
    Queensland Investment Corporation

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.